Use of complement inhibitory proteins to treat spinal cord...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/17 (2006.01) A61P 21/00 (2006.01)

Patent

CA 2508691

Trauma to the spinal cord initiates an inflammatory response that results in secondary injury to the surrounding tissue, thereby exacerbating the effects of the initial injury. These secondary injury effects are contributed to, in part, by the activation of complement and the associated inflammatory reaction at the site of injury. The present invention describes a method for treating and/or ameliorating these secondary effects and improving locomotor function of a vertebrate that has suffered a spinal cord injury by administering a complement inhibitory protein to the individual as soon as possible after the initial injury occurs. According to this method, by inhibiting the activation of complement, inflammation and the resulting secondary tissue injury are reduced, thereby improving the prognosis of a patient suffering a spinal cord injury.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of complement inhibitory proteins to treat spinal cord... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of complement inhibitory proteins to treat spinal cord..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of complement inhibitory proteins to treat spinal cord... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1898195

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.